Tvardi Therapeutics (69C.F) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-6.49
-4.4
-2.31
-0.23

Details

Expected EPS
-0.52277355
Actual EPS
-2.8774886000000004
Surprise EPS
-2.35
Surprise Percent
+450.43%

Description

Tvardi Therapeutics (69C.F) has reported earnings of -2.8774886000000004 per share for Q2 2025.

0 Comments

Share your thoughts